KD-025 meets primary endpoint at interim analysis of pivotal ROCKstar study in chronic GvHD Nov. 13, 2019
European Commission grants conditional marketing authorization to Ebola Zaire vaccine Ervebo Nov. 12, 2019
Interim results from phase I trial of chimeric HA-based universal influenza virus vaccine candidates Oct. 25, 2019
RSS